37 participants
Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2025-12-20
- Completion:
- 2027-07-31
Conditions
- Mantle Cell Lymphoma
Interventions
- DRUG
- OTHER
No Results Yet